BiotechTube
Discover
News
Company
Sign in
BiotechTube
Home
/
ProMIS Neurosciences
/
Dr. Neil Cashman
DN
Dr. Neil Cashman
Chief Scientific Officer and Co-Founder
ProMIS Neurosciences
Therapeutic Areas
Alzheimer's Disease
Amyotrophic Lateral Sclerosis
Parkinson's Disease
Multiple System Atrophy
Frontotemporal Dementia
ProMIS Neurosciences Pipeline
Drug
Indication
Phase
PMN310
Alzheimer's Disease
Phase 1b
PMN442
Amyotrophic Lateral Sclerosis (ALS)
Preclinical
PMN331
Parkinson's Disease / Multiple System Atrophy
Preclinical
Leadership Team at ProMIS Neurosciences
NK
Neil K. Warma
President and Chief Executive Officer
View full ProMIS Neurosciences profile